|
|
|
Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time.
Sign up now!
Already registered? Please sign in.
Alternatively, please use our pay-per-view service. |
|
|
 |
Industry Events |
 |
Connect in Pharma
14-15 September 2022, Plaexpo, Geneva, Switzerland
The new event driving innovation for pharma and biopharma businesses,
Connect in Pharma will unite key players in Pharmaceutical and
Biopharmaceutical packaging and production in Geneva on 14 – 15
September 2022.
More info >> |
|
 |
News and Press Releases |
 |
Oxford BioTherapeutics Announces Research Collaboration with ImmunoGen to Develop Novel Antibody-Drug Conjugates
OXFORD, UK and SAN JOSE, California, 13/06/2022 - Oxford
BioTherapeutics (OBT), a clinical stage oncology company with a pipeline
of immuno-oncology and Antibody Drug Conjugate (ADC)-based therapies,
today announced a multi-year collaboration to research, develop and
commercialize novel, first-in-class ADCs with ImmunoGen (IMGN), a leader
in the expanding field of ADCs for the treatment of cancer. The
companies will utilize ImmunoGen’s linker-payload technology directed to
novel targets identified via OBT's proprietary OGAP® discovery
platform. The companies will support these R&D efforts through joint
funding and by combining their respective proprietary technologies.
More info >> |
|
|
